Skip to main content

Aptean expands CAS collaboration on chemical modifications

Source Decision Insights Record Published January 12, 2026 Companies 2
Human View Machine View

2 companies named across 4 categories, one of 2 articles referencing Aptean. Previous coverage: Aptean Launches AppCentral 2.0: The AI Platform Purpose-Built for Industries (Nov 2025).

Companies mentioned

Best suited for

Seniority
Analyst
Job function
Non-Technology / Legal / Compliance
Persona
Data / AI Platform Architect
Buyer role
Practitioner / End User / Operator
Decision stage
How to start
Adoption curve
Early Adopters
Industry
Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services

Our classification, not the publisher's statement. Best suited for, not only for.

Aptean and Content Addressable Storage (CAS), a division of the American Chemical Society, announced an expanded collaboration to add a Chemical Modifications module to the Aptean GenomeQuest platform, a move presented as intended to help biotech intellectual property researchers assess patentability with greater speed and precision.

The release described plans for customers to procure the Chemical Modification module and CAS Biosequences directly through Aptean GenomeQuest and noted that the work built on the organizations' existing relationship.

The Chemical Modifications module combined Aptean GenomeQuest's search experience with CAS biological sequence data and provided detection capabilities that allowed users to combine exact positions, floating patterns, and filters on the number of modification occurrences within a sequence.

The companies said the module covered the majority of relevant use cases and provided tools to capture and review patents across diverse biological modification patterns, according to the announcement.

“By combining our intuitive IP search platform with CAS comprehensive, high-quality biosequence data we empower researchers to confidently assess intellectual property and gain insights tied to chemically modified sequences, an essential step in advancing drug development and therapeutic innovation,” said Disaster Recovery (DR). Henk Heus, Authenticity Verification Protocol (AVP) of Product and Technology at Aptean. “Expanding our collaboration with Aptean through the Chemical Modification module presents an exciting opportunity to further our mission of accelerating life sciences innovation globally by enhancing discoverability of critical biosequence data via the GenomeQuest platform.” said DR. Michael Dennis, CAS Chief Science Officer.

Availability followed a phased rollout, with beta access starting January 2026 and a full launch expected by the end of Q1 2026.

Press release, provided by Globe Newswire on behalf of Aptean. Read the original.

Mentions

Structured data (JSON-LD)

The schema.org markup this page publishes for search engines and AI agents, exactly as they read it.

[
  {
    "@context": "https://schema.org",
    "@id": "https://decisioninsights.ai/#website",
    "@type": "WebSite",
    "name": "Decision Insights",
    "potentialAction": {
      "@type": "SearchAction",
      "target": {
        "@type": "EntryPoint",
        "urlTemplate": "https://decisioninsights.ai/search/?q={search_term_string}&submit=1"
      }
    },
    "publisher": {
      "@id": "https://decisioninsights.ai/#organization"
    },
    "url": "https://decisioninsights.ai"
  },
  {
    "@context": "https://schema.org",
    "@id": "https://decisioninsights.ai/#organization",
    "@type": "Organization",
    "contactPoint": {
      "@type": "ContactPoint",
      "contactType": "customer support",
      "email": "[email protected]"
    },
    "description": "Decision Insights is a Registry of technology companies, open source projects, and industry terms, built for people and for AI agents that need sourced, structured information.",
    "logo": {
      "@type": "ImageObject",
      "url": "https://wiretap-cdn-assets.nyc3.cdn.digitaloceanspaces.com/decision-insights/[email protected]"
    },
    "name": "Decision Insights",
    "parentOrganization": {
      "@type": "Organization",
      "name": "Wiretap Labs",
      "sameAs": [
        "https://www.linkedin.com/company/wiretap-labs",
        "https://www.crunchbase.com/organization/wiretap-labs"
      ],
      "url": "https://wiretaplabs.com"
    },
    "publishingPrinciples": "https://decisioninsights.ai/standards/",
    "sameAs": [
      "https://www.linkedin.com/company/decisioninsights"
    ],
    "url": "https://decisioninsights.ai"
  },
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {
        "@type": "ListItem",
        "item": "https://decisioninsights.ai",
        "name": "Decision Insights",
        "position": 1
      },
      {
        "@type": "ListItem",
        "item": "https://decisioninsights.ai/records/",
        "name": "Records",
        "position": 2
      },
      {
        "@type": "ListItem",
        "item": "https://decisioninsights.ai/aptean-expands-cas-collaboration-on-chemical-modifications/",
        "name": "Aptean expands CAS collaboration on chemical modifications",
        "position": 3
      }
    ]
  },
  {
    "@context": "https://schema.org",
    "@id": "https://decisioninsights.ai/aptean-expands-cas-collaboration-on-chemical-modifications/#blogposting",
    "@type": "NewsArticle",
    "about": {
      "@id": "https://decisioninsights.ai/registry/aptean/#organization",
      "@type": "Organization",
      "mainEntityOfPage": "https://decisioninsights.ai/registry/aptean/",
      "name": "Aptean"
    },
    "articleSection": [
      "AI infrastructure",
      "Data Center"
    ],
    "audience": [
      {
        "@type": "Audience",
        "additionalType": "Seniority",
        "audienceType": "Analyst"
      },
      {
        "@type": "Audience",
        "additionalType": "Job function",
        "audienceType": "Non-Technology / Legal / Compliance"
      },
      {
        "@type": "Audience",
        "additionalType": "Persona",
        "audienceType": "Data / AI Platform Architect"
      },
      {
        "@type": "Audience",
        "additionalType": "Buyer role",
        "audienceType": "Practitioner / End User / Operator"
      },
      {
        "@type": "Audience",
        "additionalType": "Adoption curve",
        "audienceType": "Early Adopters"
      },
      {
        "@type": "Audience",
        "additionalType": "Industry",
        "audienceType": "Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services"
      }
    ],
    "author": {
      "@id": "https://decisioninsights.ai/author/decision-insights-signals/#person",
      "@type": "Person",
      "name": "Decision Insights Record",
      "url": "https://decisioninsights.ai/author/decision-insights-signals/"
    },
    "dateModified": "2026-08-23T13:39:06-06:00",
    "datePublished": "2026-01-12T04:52:36-07:00",
    "description": "Keyword: Aptean GenomeQuest. Aptean GenomeQuest added a Chemical Modifications module integrating CAS biosequence data to support patentability searches.",
    "headline": "Aptean expands CAS collaboration on chemical modifications",
    "isBasedOn": {
      "@type": "CreativeWork",
      "sourceOrganization": {
        "@type": "Organization",
        "name": "GlobeNewswire"
      },
      "url": "https://www.globenewswire.com/news-release/2026/01/12/3216660/29866/en/Aptean-and-CAS-Expand-Collaboration-with-Biosequence-Chemical-Modifications-Solution.html"
    },
    "keywords": [
      "Authenticity Verification Protocol",
      "Disaster Recovery"
    ],
    "mainEntityOfPage": {
      "@id": "https://decisioninsights.ai/aptean-expands-cas-collaboration-on-chemical-modifications/",
      "@type": "WebPage",
      "sdDatePublished": "2026-08-23",
      "sdPublisher": {
        "@id": "https://decisioninsights.ai/#organization"
      }
    },
    "mentions": [
      {
        "@id": "https://decisioninsights.ai/registry/aptean/#organization",
        "@type": "Organization",
        "mainEntityOfPage": "https://decisioninsights.ai/registry/aptean/",
        "name": "Aptean"
      },
      {
        "@id": "https://decisioninsights.ai/registry/empower/#organization",
        "@type": "Organization",
        "mainEntityOfPage": "https://decisioninsights.ai/registry/empower/",
        "name": "empower"
      }
    ],
    "publisher": {
      "@id": "https://decisioninsights.ai/#organization"
    }
  },
  {
    "@context": "https://schema.org",
    "@id": "https://decisioninsights.ai/author/decision-insights-signals/#person",
    "@type": "Person",
    "description": "Press releases and independent analyst research, structured into concise summaries for research and monitoring. Produced under our Standards & Methodology.",
    "name": "Decision Insights Record",
    "sameAs": [
      "https://www.linkedin.com/showcase/decisioninsights/"
    ],
    "url": "https://decisioninsights.ai/author/decision-insights-signals/"
  }
]

Is this your company? Get structured data for your own pages